Hematology/Oncology Clinics of North America This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neurofibromatoses
The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic manifestations. Neurofibromatosis type 1 is the most prevalent of these conditions and has the most variable phenotype and highest risk of malignant tumor formation. Neurofibromatosis type 2 has no associated malignant tumors but does carry significant morbidity, including deafness, facial weakness, and physical disability. Schwannomatosis is the least prevalent of these disorders and is characterized primarily by nonvestibular schwannomas and pain. (Source: Hematology/Oncology ...
Source: Hematology/Oncology Clinics of North America - October 27, 2021 Category: Cancer & Oncology Authors: Justin T. Jordan, Scott R. Plotkin Source Type: research

Inherited Bleeding Disorders
HEMATOLOGY/ONCOLOGY CLINICS OF NORTH AMERICA (Source: Hematology/Oncology Clinics of North America)
Source: Hematology/Oncology Clinics of North America - October 26, 2021 Category: Cancer & Oncology Authors: Nathan T. Connell Source Type: research

Copyright
ELSEVIER (Source: Hematology/Oncology Clinics of North America)
Source: Hematology/Oncology Clinics of North America - October 26, 2021 Category: Cancer & Oncology Source Type: research

Contributors
GEORGE P. CANELLOS, MD (Source: Hematology/Oncology Clinics of North America)
Source: Hematology/Oncology Clinics of North America - October 26, 2021 Category: Cancer & Oncology Source Type: research

Contents
Nathan T. Connell (Source: Hematology/Oncology Clinics of North America)
Source: Hematology/Oncology Clinics of North America - October 26, 2021 Category: Cancer & Oncology Source Type: research